Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 16 de 16
Filtrar
1.
East Mediterr Health J ; 20(1): 24-32, 2014 Feb 11.
Artículo en Inglés | MEDLINE | ID: mdl-24932930

RESUMEN

Exclusive breastfeeding is the best form of nutrition for infants in the first 6 months of life. The aim of this study was to determine the prevalence of exclusive breastfeeding in Tehran, Islamic Republic of Iran in the first 6 months of life, and the factors that influence it. In a population-based, cross-sectional study 538 mothers with children aged 6-24 months completed an interview questionnaire. Only 46.5% of mothers exclusively breastfed their infant in the first 6 months of life. In multivariate analysis formula supplementation in the hospital (OR = 0.41, 95% CI: 0.17-0.95) and mother receiving conflicting infant feeding advice (OR = 0.53, 95% CI: 0.37-0.78) had a negative effect on exclusive breastfeeding. Mother's intention to exclusively breastfeed (OR = 5.85, 95% CI: 2.88-11.9) and infant having first breast contact 6-30 minutes after delivery (OR = 2.35, 95% CI: 1.17-4.72) had positive effects on exclusive breastfeeding.


Asunto(s)
Lactancia Materna/estadística & datos numéricos , Estudios Transversales , Femenino , Humanos , Lactante , Recién Nacido , Irán/epidemiología , Prevalencia , Encuestas y Cuestionarios
2.
Scand J Immunol ; 78(3): 285-90, 2013 Sep.
Artículo en Inglés | MEDLINE | ID: mdl-23721058

RESUMEN

Sera from 84 haemodialysis (HD) patients and 68 healthy blood donors were analysed with commercially available ELISA techniques for fibroblast growth factor 23 (FGF-23), hepatocyte growth factor (HGF), interleukin-6 (Il-6), high-sensitivity C-reactive protein (hs-CRP) and soluble urokinase plasminogen activator receptor (suPAR), to find a possible correlation of FGF-23 and HGF with the earlier recognized inflammatory markers Il-6 and hs-CRP or suPAR. All patients studied had significantly elevated levels of FGF-23, HGF, hs-CRP and suPAR as compared to the controls. Il-6 and hs-CRP correlated for patients (R = 0.6) as well as for patients and controls altogether. Ln (natural logarithm) of HGF correlated weakly with Ln Il-6 and Ln CRP (R 0.28-0.37). Ln FGF-23 correlated only with Ln HGF (r = -0.25) in controls. Ln HGF correlated with ln suPAR (r = 0.6) in both patients and controls. Although elevated as compared to controls, we found no correlation of FGF-23 with the recognized inflammatory markers Il-6, hs-CRP, nor HGF or the new marker suPAR in HD patients. Ln HGF correlated with Ln Il-6, Ln CRP and Ln suPAR. Although probably involved in vessel disease, FGF-23 and HGF may play other roles than acting in inflammatory vessel disease in HD patients. Further studies are necessary to evaluate the role of these immunological markers in chronic haemodialysis patients with atherosclerosis.


Asunto(s)
Biomarcadores/sangre , Diálisis Renal , Anciano , Proteína C-Reactiva/análisis , Femenino , Factor-23 de Crecimiento de Fibroblastos , Factores de Crecimiento de Fibroblastos/sangre , Factor de Crecimiento de Hepatocito/sangre , Humanos , Inflamación , Interleucina-6/sangre , Masculino , Persona de Mediana Edad , Receptores del Activador de Plasminógeno Tipo Uroquinasa/sangre
3.
Results Immunol ; 2: 7-12, 2011.
Artículo en Inglés | MEDLINE | ID: mdl-24371561

RESUMEN

Hepatocyte growth factor (HGF) is an angiogenic, cardioprotective factor important for tissue and vascular repair. High levels of HGF are associated with chronic inflammatory diseases, such as coronary artery disease (CAD) and periodontitis, and are suggested as a marker of the ongoing atherosclerotic event in patients with CAD. Periodontal disease is more prevalent among patients with CAD than among healthy people. Recent studies indicate a reduced biological activity of HGF in different chronic inflammatory conditions. Biologically active HGF has high affinity to heparan sulfate proteoglycan (HSPG) on cell-membrane and extracellular matrix. The aim of the study was to investigate the serum concentration and the biological activity of HGF with ELISA and surface plasmon resonance (SPR), respectively, before and at various time points after percutaneous coronary intervention (PCI) in patients with CAD, and to examine the relationship with periodontal condition. The periodontal status of the CAD patients was examined, and the presence of P. gingivalis in periodontal pockets was analyzed with PCR. The HGF concentration was significantly higher, at all time-points, in patients with CAD compared to the age-matched controls (P< 0.001), but was independent of periodontal status. The HGF concentration and the affinity to HSPG adversely fluctuated over time, and the biological activity increased one month after intervention in patients without periodontitis. We conclude that elevated concentration of HGF but with reduced biological activity might indicate a chronic inflammatory profile in patients with CAD and periodontitis.

4.
J Indian Soc Pedod Prev Dent ; 25(4): 174-6, 2007.
Artículo en Inglés | MEDLINE | ID: mdl-18007103

RESUMEN

The purpose of this study was to assess the epidemiology and some of the possible risk factors causing oral cleft in Tehran. The study was a 7-year retrospective study from March 1998 to March 2005. Twenty-five live births with cleft lip and/or palate (CL+/-P) were born between 20 March 1998 and 20 March 2005 from the total of 11,651 live births in a maternity hospital in Tehran. After recognizing the child as a cleft patient, previous and following children born were recognized as a noncleft sample. Cleft and noncleft samples were compared for variables such as gender, mother's age, parity, consanguineous marriage and infant's weight, and then analyzed with Chi-square. The overall incidence was 2.14 per 1000 live births. CL+ P is more prevalent, which was 52% and the least incidence was for "only cleft lip'' patients, which was 12%. This study reveals that the incidence of oral clefts in Tehran is higher than many other countries. Consanguineous marriage and low birth weight in cleft group were significant statistically from those of noncleft group.


Asunto(s)
Labio Leporino/epidemiología , Fisura del Paladar/epidemiología , Peso al Nacer , Consanguinidad , Estudios Epidemiológicos , Femenino , Humanos , Incidencia , Recién Nacido de Bajo Peso , Recién Nacido , Irán/epidemiología , Masculino , Edad Materna , Paridad , Embarazo , Estudios Retrospectivos , Factores de Riesgo , Factores Sexuales
5.
East Mediterr Health J ; 13(6): 1308-18, 2007.
Artículo en Inglés | MEDLINE | ID: mdl-18341181

RESUMEN

To identify the incidence rate and risk factors of neonatal hypothermia at referral hospitals in Tehran, Islamic Republic of Iran, 900 neonates were randomly selected. Body temperature was measured repeatedly at different time points after birth. More than 50% became hypothermic soon after birth. Multiple regression analysis showed that low birth weight, low gestational age environmental temperature, low Apgar score, multiple pregnancy and receiving cardiopulmonary resuscitation were significantly associated with hypothermia. These findings suggested that there is an urgent need to sensitize and educate all levels of staff dealing with neonates in our country.


Asunto(s)
Hospitales Universitarios , Hipotermia/epidemiología , Hipotermia/etiología , Unidades de Cuidado Intensivo Neonatal , Puntaje de Apgar , Peso al Nacer , Distribución de Chi-Cuadrado , Femenino , Edad Gestacional , Mortalidad Hospitalaria , Hospitales Universitarios/estadística & datos numéricos , Humanos , Hipotermia/diagnóstico , Hipotermia/prevención & control , Incidencia , Mortalidad Infantil , Recién Nacido , Unidades de Cuidado Intensivo Neonatal/estadística & datos numéricos , Irán/epidemiología , Modelos Logísticos , Masculino , Análisis Multivariante , Vigilancia de la Población , Prevalencia , Derivación y Consulta , Análisis de Regresión , Factores de Riesgo , Índice de Severidad de la Enfermedad , Factores de Tiempo
6.
East Mediterr Health J ; 11(4): 716-22, 2005 Jul.
Artículo en Inglés | MEDLINE | ID: mdl-16700388

RESUMEN

Antenatal corticosteroids are still not routinely used in the Islamic Republic of Iran to promote lung maturity in premature neonates. In a retrospective review of records at Imam Hospital, Tehran, we compared 140 premature neonates born in 2000 whose mothers received dexamethasone antenatally with 142 born in 1995 whose mothers did not receive treatment. There were no significant differences between the groups in mothers' age; neonates' birth weight, gestational age or sex; route of delivery and multiple gestation; underlying maternal disease; or adverse events in labour. The incidence of respiratory distress syndrome was significantly lower in the dexamethasone-treated group (18.6% versus 35.9%). Mortality (5.7% versus 14.8%) and use of the neonatal intensive care unit (12.9% versus 21.1%) were also significantly lower among those who had received treatment.


Asunto(s)
Antiinflamatorios/uso terapéutico , Dexametasona/uso terapéutico , Glucocorticoides/uso terapéutico , Atención Prenatal/métodos , Síndrome de Dificultad Respiratoria del Recién Nacido/prevención & control , Adulto , Causalidad , Parto Obstétrico/métodos , Femenino , Edad Gestacional , Hospitales Generales , Humanos , Incidencia , Mortalidad Infantil , Recién Nacido , Unidades de Cuidado Intensivo Neonatal/estadística & datos numéricos , Irán/epidemiología , Masculino , Trabajo de Parto Prematuro/prevención & control , Embarazo , Embarazo de Alto Riesgo , Síndrome de Dificultad Respiratoria del Recién Nacido/epidemiología , Síndrome de Dificultad Respiratoria del Recién Nacido/etiología , Estudios Retrospectivos , Índice de Severidad de la Enfermedad , Resultado del Tratamiento
7.
Scand J Clin Lab Invest ; 64(6): 589-97, 2004.
Artículo en Inglés | MEDLINE | ID: mdl-15370465

RESUMEN

In order to evaluate the accuracy and reproducibility of determination of hepatocyte growth factor (HGF) levels in faeces, the stability of HGF in samples processed in different ways was investigated. An ELISA method was used for determination of HGF concentrations. Faeces samples from healthy controls and patients with infectious diarrhoea were studied. It was found that faeces HGF concentration remained stable irrespective of whether samples were freeze-thawed several times, kept for 6, 12 or 24 h at room temperature or refrigerated for 6, 12, 24 or 36 h; the levels of HGF did not change significantly when samples were freeze-dried. Adding protease inhibitor to the faeces samples did not affect the HGF levels. There were no significant differences between HGF levels using phosphate buffered saline (PBS) (pH 7.4) or NaCL as buffer, but it was observed that levels of HGF were significantly lower in the samples that were diluted in distilled water. Although both HGF and albumin through various mechanisms may increase in faeces during infectious diarrhoea, there was no significant correlation between faeces HGF levels and albumin levels, which might indicate local production of HGF in the bowel in response to infection. It is concluded that determination of faeces HGF levels is feasible with a high degree of stability. Increased HGF levels in faeces might represent a local production of HGF during bowel injury and might be of use as a diagnostic and monitoring assay.


Asunto(s)
Criopreservación/métodos , Disentería/metabolismo , Heces/química , Factor de Crecimiento de Hepatocito/análisis , Adolescente , Adulto , Disentería/diagnóstico , Ensayo de Inmunoadsorción Enzimática , Femenino , Humanos , Masculino , Persona de Mediana Edad , Inhibidores de Proteasas/farmacología , Reproducibilidad de los Resultados
8.
J Dermatolog Treat ; 13(2): 81-6, 2002 Jun.
Artículo en Inglés | MEDLINE | ID: mdl-12060507

RESUMEN

BACKGROUND: Hepatocyte growth factor (HGF) is a heparin-binding protein with mitogenic, motogenic and morphogenic activities for various cell types. The regenerative properties of HGF have been the object of several animal and in vitro studies in recent years. OBJECTIVE: To investigate the physiological and therapeutic effects of HGF on chronic leg ulcers. METHODS: HGF in gel form was locally applied, once daily for 7 days, to 15 of 19 chronic leg ulcers in 11 elderly patients. All patients had previously been treated by conventional methods and their leg ulcers had been in stable conditions for between 1 and 14 years. Any signs of allergy, discomfort or pain were reported daily. Microcirculation perfusion in the ulcers, compared to the intact contiguous skin, was determined by laser Doppler at the beginning of the study, after 1 week and again after 3 months (in seven patients). Ulcer size and characteristics were also documented. RESULTS: It was observed that microcirculatory perfusion, which might reflect the angiogenic effect of HGF, was statistically significantly correlated (r = 0.94, p < 0.002) to ulcer area reduction in the treated ulcers. Excellent (84-100% area reduction) or partial healing (58-59%) was seen in eight out of 11 patients. No control group was included in this pilot study, which must be completed by proper control studies. CONCLUSION: This study suggests that HGF may heal chronic leg ulcers, possibly by improving the microcirculation. Proper control studies need to be performed.


Asunto(s)
Factor de Crecimiento de Hepatocito/uso terapéutico , Úlcera de la Pierna/tratamiento farmacológico , Cicatrización de Heridas/efectos de los fármacos , Anciano , Enfermedad Crónica , Femenino , Geles , Humanos , Pierna/irrigación sanguínea , Úlcera de la Pierna/fisiopatología , Microcirculación/efectos de los fármacos , Persona de Mediana Edad , Proyectos Piloto
9.
Scand J Infect Dis ; 34(2): 127-30, 2002.
Artículo en Inglés | MEDLINE | ID: mdl-11928843

RESUMEN

Acute serum levels of hepatocyte growth factor (HGF) were studied in 6 clinical groups with (i) gastroenteritis, (ii) skin and soft tissue infection, (iii) urinary tract infection, (iv) septicemia, (v) influenza, and (vi) chronic hepatitis C in comparison with a normal control group using an enzyme-linked immunosorbent assay method. We found that serum HGF levels were significantly higher in patients with acute infectious diseases (p < 0.0001) compared to patients with chronic viral hepatitis and healthy controls. Serum HGF and CRP levels were correlated significantly (r=0.65, p < 10(-7)). We conclude that serum HGF levels are elevated in patients with acute infectious diseases.


Asunto(s)
Infecciones Comunitarias Adquiridas/sangre , Factor de Crecimiento de Hepatocito/sangre , Enfermedad Aguda , Adulto , Anciano , Anciano de 80 o más Años , Análisis de Varianza , Biomarcadores/sangre , Enfermedad Crónica , Femenino , Gastroenteritis/sangre , Humanos , Gripe Humana/sangre , Masculino , Persona de Mediana Edad , Sepsis/sangre , Enfermedades Cutáneas Infecciosas/sangre , Infecciones Urinarias/sangre
10.
Respir Med ; 96(2): 115-9, 2002 Feb.
Artículo en Inglés | MEDLINE | ID: mdl-11860168

RESUMEN

Hepatocyte growth factor (HGF) is a protein produced by mesenchymal cells in many organs, which can stimulate epithelial growth. An enhanced production and concentration of HGF is observed after injuries. The lung is one of the major sources of HGF. By cooling exhaled air, a condensate is formed containing molecules from bronchi and alveoli. In order to investigate HGF-concentration and time course in pneumonia, paired serum and exhaled breath condensate was collected from 10 patients with pneumonia, 10 patients with non-respiratory infections and 11 healthy controls. The concentration of HGF was measured by an immunoassay kit. In the acute phase HGF-levels in breath condensate and serum were significantly higher in the patients with pneumonia compared to the control groups. Similar concentrations in breath condensate were seen in healthy controls and in patients with non-respiratory infections. In the patients with pneumonia a decrease in serum HGF was seen already after 4-7 days while HGF values in breath condensate remained elevated even after 4-6 weeks. These results might imply local product on of HGF in the lungs and a long repair and healing process after pneumonia.


Asunto(s)
Factor de Crecimiento de Hepatocito/análisis , Neumonía/metabolismo , Adulto , Anciano , Anciano de 80 o más Años , Análisis de Varianza , Biomarcadores/análisis , Biomarcadores/sangre , Pruebas Respiratorias , Bronquios/química , Estudios de Casos y Controles , Femenino , Factor de Crecimiento de Hepatocito/sangre , Humanos , Masculino , Persona de Mediana Edad , Alveolos Pulmonares/química , Factores de Tiempo
11.
Med Biol Eng Comput ; 39(5): 594-600, 2001 Sep.
Artículo en Inglés | MEDLINE | ID: mdl-11712658

RESUMEN

A new non-electric transport incubator has been developed for transferring babies between health facilities in developing countries. The temperature performance of this prototype was compared with a commercial electric incubator. The warm-up time for the prototype was 51.8 min, compared with 48.1 min for the electric incubator. Forty-five non-distressed premature babies, aged 24-72 h, with a gestational age of less than 37 weeks, were continuously evaluated for a 2 h period. Twenty-five babies, with a mean weight of 2073 g (range 1500-2500 g), were studied in the prototype, and 20 babies, with a mean weight of 2076g (range 1550-2500 g), were studied in the electrical incubator. The rectal and abdominal skin temperature, heart rate, oxygen saturation and respiratory rate of the babies were recorded. The temperature, oxygen and humidity level of the canopy and the room temperature were also measured. The SaO2, heart rate and respiratory rate were within the normal range (in the prototype: 96.5%, 130.5 beats min(-1) and 43 breaths min(-1), respectively; and, in the electric incubator: 96.5%, 128.5 beats min(-1) and 40 breaths min(-1), respectively). No evidence of carbon dioxide narcosis, hypoxia, acidosis or adverse thermoregulatory behaviour were observed in the two groups. The mean rectal temperature for both groups was within the range 36.5 degrees C-37.5 degrees C. There was no significant difference between the measurements of the two groups. The level of oxygen inside the canopy was 21%, and no decrease was observed. The new nonelectric transport incubator confirmed its safety and efficiency in providing a warm environment for non-distressed premature babies over a 2 h period.


Asunto(s)
Incubadoras para Lactantes , Recien Nacido Prematuro/fisiología , Transferencia de Pacientes , Regulación de la Temperatura Corporal , Países en Desarrollo , Diseño de Equipo , Humanos , Recién Nacido
12.
J Infect Dis ; 181(6): 2092-4, 2000 Jun.
Artículo en Inglés | MEDLINE | ID: mdl-10837201

RESUMEN

The organotrophic functions of the hepatocyte growth factor (HGF) have been the subject of several studies. In the more recent studies, this function has been reported in the brain. In the present study, we have measured the levels of HGF in cerebrospinal fluid (CSF) and sera from 78 patients divided into 6 different groups according to central nervous system (CNS) infection and control. Quantitative measurements of HGF in the CSF and serum were performed by an enzyme-linked immunosorbent assay. Elevated values of CSF HGF were found in the patients with acute bacterial/probable bacterial meningitis (P<.001), compared with nonbacterial CNS infections and facial palsy, as well as with a control group without signs of CNS involvement. The values of CSF HGF were not correlated to blood-brain-barrier disruption in the groups. These observations might indicate an intrathecal production of HGF in acute bacterial/probable bacterial meningitis.


Asunto(s)
Factor de Crecimiento de Hepatocito/líquido cefalorraquídeo , Meningitis Bacterianas/líquido cefalorraquídeo , Meningitis/líquido cefalorraquídeo , Enfermedad Aguda , Adolescente , Adulto , Anciano , Anciano de 80 o más Años , Humanos , Persona de Mediana Edad
13.
Scand J Infect Dis ; 30(4): 405-9, 1998.
Artículo en Inglés | MEDLINE | ID: mdl-9817523

RESUMEN

Hepatocyte growth factor (HGF) is a multifunctional growth factor. After lung injury HGF is secreted in the lung and promotes reconstruction of the damaged organ. We measured, retrospectively, the serum HGF concentrations collected on admission in 55 patients with bacterial pneumonia, using an enzyme-linked immunosorbent assay (ELISA). The patients were divided into 3 groups: Group 1 was survivors with normal liver function (n = 14), Group 2 was survivors with abnormal liver function (n = 31) and Group 3 was non-survivors (n = 10). Median concentrations of HGF were elevated in Groups 1 and 2; and no statistically significant difference between these 2 groups was found. Group 3 had a median HGF concentration within the reference range, significantly lower than both Group 1 and Group 2. In addition LDH was significantly higher in non-survivors as compared with survivors. The combination of LDH and HGF concentrations discriminated between survivors and non-survivors (sensitivity 0.90 and specificity 0.96). The results support the hypothesis that increased levels of HGF might be a natural part of the healing process of lung injury, irrespective of liver involvement, and that patients without increased HGF levels, especially those with concomitant liver function impairment, may have a poor prognosis.


Asunto(s)
Factor de Crecimiento de Hepatocito/sangre , Neumonía Bacteriana/mortalidad , Anciano , Anciano de 80 o más Años , Ensayo de Inmunoadsorción Enzimática , Femenino , Humanos , L-Lactato Deshidrogenasa/sangre , Pruebas de Función Hepática , Masculino , Persona de Mediana Edad , Neumonía Bacteriana/sangre , Valor Predictivo de las Pruebas , Pronóstico , Estudios Retrospectivos , Sensibilidad y Especificidad , Análisis de Supervivencia
15.
Scand J Infect Dis ; 29(6): 635-8, 1997.
Artículo en Inglés | MEDLINE | ID: mdl-9571751

RESUMEN

Candida glabrata is a well-known cause of lower urinary tract infections. Systemic infections caused by this organism are less common, but have increased dramatically in recent years. Prosthesis infection caused by C. glabrata is extremely rare. We report a case of prosthesis failure due to C. glabrata 5 y after candidaemia and pyelonephritis caused by this organism. The same C. glabrata strain was isolated from both infections, as confirmed by the random amplified polymorphic DNA (RAPD) method.


Asunto(s)
Candidiasis/microbiología , Prótesis de Cadera/microbiología , Infecciones Relacionadas con Prótesis/microbiología , Pielonefritis/microbiología , Sepsis/microbiología , Antifúngicos/uso terapéutico , Candidiasis/tratamiento farmacológico , ADN de Hongos/análisis , Femenino , Flucitosina/uso terapéutico , Humanos , Itraconazol/uso terapéutico , Persona de Mediana Edad , Infecciones Relacionadas con Prótesis/tratamiento farmacológico , Pielonefritis/tratamiento farmacológico , Técnica del ADN Polimorfo Amplificado Aleatorio , Sepsis/tratamiento farmacológico
SELECCIÓN DE REFERENCIAS
DETALLE DE LA BÚSQUEDA
...